SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-024230
Filing Date
2021-06-16
Accepted
2021-06-16 18:34:47
Documents
1
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3990
  Complete submission text file 0000899243-21-024230.txt   5609
Mailing Address 6200 LOOKOUT RD. BOULDER CO 80301
Business Address 6200 LOOKOUT RD. BOULDER CO 80301 720.643.5200
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103
Business Address
Kiselak Tomas (Reporting) CIK: 0001830177 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 211022738